NURS 460 Exam 3

The Somatization Phenomenon

• Somatization is the psychological and emotional expression of stress through physical symptoms

• Diagnostic Rule: Confirm medical exclusion before attributing symptoms purely to somatization.

• Core Mechanism

  • Psychological distress converts directly into physical bodily complaints without organic etiology.

  • Patients experience genuine, authentic physical pain rather than voluntary deception.

• Sensory Displacement

  • Physical symptoms mask unexpressed anxiety, depression, and trauma.

• Biopsychosocial Web

  • Driven by neural hyper-reactivity, cultural idioms, and family distress.

• Cultural Framing

  • Cultural stigma against mental illness often amplifies somatic presentations.

CLINICAL PROFILE of Somatic Symptom Disorder (SSD)

• Somatic Symptom Disorder (SSD): characterized by a focus on somatic (physical) symptoms, such as pain or fatigue, to the point of excessive concern, preoccupation, and fear

• Epidemiology:Affects 5% to 7% of adults; highly comorbid with Major Depressive Disorder and Generalized Anxiety.

• Clinical Hallmarks

  • Authentic, distressing bodily symptoms without organic findings.

  • Persistent severe functional disability across daily roles.

  • Common symptoms for primary care visits are chest pain, fatigue, dizziness, headache, swelling, back pain, shortness of breath, insomnia, abdominal pain, and numbness. (young adults have low back pain while children have abdominal pain) 

• Cognitive Fixation

  • Disproportionate thoughts regarding illness severity.

  • High health-related anxiety consuming daily life.

  • Limited Self-compassion: Treating oneself with kindness and understanding during difficulties; it promotes emotional resilience, while low self-compassion is associated with increased physical and psychological symptoms and poorer quality of life

• Medical Utilization

  • Chronic clinic shopping and multiple redundant exams.

  • Frustration when negative laboratory workups occur.

  • Treatment: Hypnotherapy is effective; CBT combined with medication (e.g., amitriptyline or SSRIs like fluoxetine) may also help.

DIFFERENTIAL ASSESSMENT of Illness Anxiety Disorder

• Illness Anxiety Disorder: characterized by extreme worry and fear about the possibility of having a disease (chronic and relapsing) 

• Key Indicator: Continuous somatic hyper-vigilance, pulse checking, and self-scanning.

  • Media exposure: Health-related media and social media can increase health fears and stress, especially after traumatic events.

  • Loneliness: Perceived social isolation triggers stress and increased self-focus, potentially contributing to illness anxiety, especially in older adults.

• Preoccupation Over Sensation

  • Obsessive fear of harboring a severe undiagnosed illness persisting for 6 or more months.

  • Somatic symptoms are either completely absent or extremely mild in physiological reality.

• Care-Seeking Type

  • Frequent medical consultations, diagnostic requests, and reassurance seeking.

• Care-Avoidant Type

  • Severe clinic phobia driven by fear of receiving fatal medical diagnoses.

• Treatment: Symptom-relief medications, SSRIs for anxiety, CBT/iCBT, and sometimes ECT for older adults with concurrent depression

FUNCTIONAL NEUROLOGY of Conversion Disorder

• Conversion Disorder (FNSD): functional neurological disorder, manifests itself as neurological symptoms in the absence of a neurological diagnosis -> emotional conflicts or stressors are transferred to physical symptoms

• Clinical Caution:Never directly confront conversion symptoms; support emotional recovery while validating function.

• Sensory-Motor Deficits

  • Loss of vision, sudden paralysis, aphonia, numbness, or psychogenic seizures.

• La Belle Indifférence

  • Bizarre lack of emotional concern regarding severe acute physical deficits.

• Incompatible Neuro Anatomy

  • Objective neurological testing contradicts clinical patterns (e.g., Hoover sign).

• Treatment modalities: Severe symptoms may require narcoanalysis or hypnosis; other treatments include BOPT (body awareness and movement), DBT (emotional regulation and distress tolerance), psychodrama (role-playing), and physical therapy to improve motor function and provide support.

CONSCIOUS SYMPTOM PRODUCTION - Factitious Disorder vs. Malingering

• Key Distinction: Factitious seeks emotional attention; malingering seeks concrete material reward.

• PSYCHIATRIC ILLNESS

  • Factitious Disorder

    • Deliberate fabrication of signs to assume the patient/sick role.

    • Motivated by psychological dependency and attention needs.

    • Imposed on Self or Imposed on Another (Münchausen by proxy).

      • Factitious Disorder Imposed on Self: Patients intentionally fake or induce illness to assume the sick role, often seeking unnecessary treatments and visiting multiple providers, risking severe complications.

      • Factitious Disorder Imposed on Another (Munchausen Syndrome by Proxy): A caregiver deliberately fakes or induces illness in a dependent for attention or other rewards, causing unnecessary treatments, serious harm, or even death.

    • Treatment: CBT focused on childhood trauma may help; antidepressants and antipsychotics are generally ineffective.

• SECONDARY GAIN ONLY

  • Malingering

    • Intentional symptom deception or exaggerating (vague pain) motivated by external incentives.

    • Financial compensation, disability fraud, avoiding military/court duty.

    • Classified as a non-psychiatric condition in DSM-5-TR.

      • associated with childhood abuse or neglect and antisocial, narcissistic, or borderline personality disorders

EVIDENCE-BASED IMPLEMENTATION - Six Strategic Principles for Somatic Care

• Outcome Measure: Patient reports continued mild symptoms but actively attends social roles.

  • 1. Continuity of Care

    • Maintain one primary care contact to stop unnecessary provider hopping.

  • 2. Restrict Redundant Testing

    • Avoid invasive diagnostics unless new objective symptoms emerge.

  • 3. Frequent, Brief Visits to reduce doctor shopping 

    • Schedule regular checkups before crisis exacerbations occur.

  • 4. Concrete Physical Exams

    • Always examine reported sites to validate patient trust and respect.

  • 5. Eliminate Disparagement

    • Never imply symptoms are imaginary or fake.

  • 6. Incremental Realistic Goals

    • Target improved functional coping rather than total symptom absence.

• Assertiveness training and exercise: Help patients express needs directly and reduce somatic symptoms; daily range-of-motion exercises (15–20 minutes) and regular walks improve control, increase endorphins, and decrease anxiety.

• CBT: The most evidence-based treatment for somatic disorders; helps patients reframe negative thoughts, regain control, and break the cycle of pain, distress, and excessive health-seeking behaviors.

HOLISTIC INTERACTIONS - Psychological Factors Affecting Medical Illness

• Nursing Mandate: Screen routinely for Adverse Childhood Experiences (ACEs) and social isolation.

• Cardiovascular Burden

  • Chronic autonomic stress elevates cortisol, accelerating coronary artery atherosclerosis.

  • Depression doubles post-myocardial infarction mortality.

• Immunological Blunting

  • Sustained emotional distress alters natural killer cell function and impairs cellular healing/damage to blood vessels.

  • Complicates diabetic glycemic control and wound recovery.

• Adverse Childhood Experiences (ACEs): Childhood trauma can cause long-term physical health problems and neurobiological changes. 

  • Resilient coping is the ability to recover from adversity and reduce distress and physical symptoms despite past trauma.

• Treatment Adherence

  • Severe hopelessness and anxiety interfere with essential medication regimens.

  • Requires motivational interviewing and family involvement.

Sleep info 

• Amount of time spent working, engaging in academic activities, and traveling to and from work and school are the strongest determinants of total sleep time (strict vs irregular bed times) 

• Sleep reduction causes excessive sleepiness

• Sleep deprivation occurs when insufficient sleep causes impaired functioning, negatively affecting quality of life, health, and safety.

  • Sleep disruption causes short-term stress, pain, mood, memory, and performance problems, while 

  • long-term effects include cardiovascular disease, obesity, metabolic disorders, type 2 diabetes, cancer, and increased mortality

• Children and adolescents are most vulnerable

• Staying awake for 17–19 hours can impair psychomotor performance similarly to alcohol intoxication (BAC 0.05–0.1%), potentially exceeding the legal driving limit of 0.08%

• Sleep deprivation can cause 1–10-second episodes of microsleep, reducing task performance and increasing the risk of errors

• Excessive sleep (over 9 hours in adults) is associated with increased risks of stroke, obesity, metabolic syndrome, depression, headaches, and mortality

NORMAL NEUROPHYSIOLOGY - Sleep Architecture & Cycle Progression

• Sleep is measured using an EEG and consists of two stages: non-rapid eye movement (NREM) and rapid eye movement (REM) sleep

• Cycle Dynamics:Adults cycle through NREM-REM intervals every 90 to 120 minutes (4 to 6 total cycles per night).

• STAGE N1 (2%–5%): Sleep Latency - wakefulness to sleep 

  • Light transition from wakefulness; easily disrupted by ambient noises, temp declines and muscles relax 

• STAGE N2 (45%–55%): Stable Sleep

  • Reduced heart rate and RR, slowing electroencephalogram, and stable core rest.

• STAGE N3 (DELTA, 13%-23%): Slow-Wave Sleep

  • Deep restorative physiology, hormone release, and immune regeneration, reduction in heart rate, respiratory rate, blood pressure, and response to external stimuli

• REM SLEEP (20%–25%): Dreaming & Atonia

  • Muscle atonia prevents acting out vivid dreams; consolidates emotional memory, myoclonic twitches of the facial and limb muscles

• NREM sleep predominates during the first half of the night, while REM sleep increases during the second half, with the longest REM period occurring just before awakening, making dreams easier to remember

• Sleep architecture is the organization of NREM and REM sleep shown in a hypnogram, which helps assess sleep continuity, while sleep fragmentation involves disrupted sleep stages, frequent awakenings, and shifts between stages.

NEUROREGULATORY DYNAMICS - The Two-Process Model of Sleep

• Sleep architecture and sleep efficiency (ratio of sleep time to time spent in bed) change throughout the lifespan as a person ages

• Clinical Insight: Caffeine antagonizes adenosine receptors, falsely blocking the biological homeostatic signal.

  • Amphetamines increase dopamine and norepinephrine to promote wakefulness and SSRIs may initially cause insomnia or drowsiness

• Homeostatic Sleep Drive

  • Adenosine accumulation across waking hours steadily amplifies sleep pressure.

  • Discharged during restorative stage N3 slow-wave sleep.

• Circadian Wake Drive (promotes wakefulness based on the body's internal clock) 

  • Suprachiasmatic nucleus (SCN) acts as the hypothalamic master clock, thalamus/midbrain

  • Entrained by environmental Zeitgebers (light, meal timing, and activity).

• regulate hormones, body temperature, metabolism, autonomic functions, cognitive and psychomotor performance, attention, memory, and emotions

• Wake-promoting neurotransmitters: Dopamine, norepinephrine, serotonin, acetylcholine, histamine, glutamate, and orexin; sleep-promoting neurotransmitters: Adenosine, GABA, and galanin

• Most adults need 7–8 hours of sleep, but basal sleep requirement is the amount needed for optimal alertness and performance; it can be estimated by averaging several nights of uninterrupted sleep without an alarm

SYSTEMIC PATHOLOGY- Physiological Toll of Sleep Deprivation

• Healthy People 2030 Mandate: Elevate public sleep hygiene to prevent industrial, transportation, and health fatalities.

• Acute Manifestations

  • Severe cognitive impairment and micro-sleep events.

  • Heightened emotional reactivity and anxiety.

  • Impaired motor coordination elevating road accidents.

• Chronic Pathologies

  • Metabolic syndrome and Type 2 diabetes mellitus.

  • Systemic hypertension and cardiovascular disease.

  • Elevated all-cause mortality and depressive episodes.

DIAGNOSTIC ETIOLOGY - Insomnia Disorder & The 3P Model

• Characterized by dissatisfaction with quantity or quality of sleep

• Diagnostic Threshold: Sleep induction or maintenance failure ≥3 nights per week for at least 3 months.

• STEP 1: Predisposing

  • Underlying biological vulnerability, anxiety trait, or familial history (poor-quality sleep, history of depression and anxiety, or a state of hyperarousal) 

  • Pre-existing baseline.

• STEP 2: Precipitating

  • Acute environmental trigger (divorce, job loss, illness, or acute stress).

  • Initiating event.

• STEP 3: Perpetuating

  • Maladaptive habits maintaining chronic insomnia (clock-watching, naps, bed-reading, excessive caffeine or alcohol use).

  • Target for CBT-I.

HYPERSOMNIA SYNDROMES - Narcolepsy & Hypersomnolence Disorder

• Safety Critical:Assess driving and heavy machinery risks immediately upon symptom identification.

• Narcolepsy (uncontrollable urge to sleep) Manifestations

  • disturbed nighttime sleep with multiple middle-of-the-night awakenings and automatic behaviors characterized by memory lapses

  • Sleep Attacks: Sudden irresistible compulsion to sleep.

  • Cataplexy: Sudden bilateral muscle tone loss during strong emotion.

    • usually triggered by strong emotions such as anger, fear, frustration, and joy, or even the act of laughing

  • Hypnagogic Hallucinations: Vivid dreams occurring during sleep onset.

  • Sleep paralysis: an inability to move or speak during the transition from sleep to wakefulness

  • Pathology: Hypothalamic hypocretin/orexin deficiency.

  • Treatment: Encourage naps, exercise, and a balanced diet

    • Medications include stimulants (modafinil, armodafinil, methylphenidate, amphetamine) and nonstimulants (pitolisant and solriamfetol) 

      • Pitolisant: Histamine-3 receptor antagonist/inverse agonist; side effects include insomnia, nausea, and anxiety.

      • Solriamfetol: Blocks dopamine and norepinephrine reuptake; avoid with MAOIs and monitor blood pressure and heart rate.

      • Cataplexy treatment: Sodium oxybate (Xyrem) treats cataplexy and excessive daytime sleepiness by improving nighttime sleep; SSRIs and tricyclic antidepressants may also be used off-label to suppress REM-related paralysis.

• Hypersomnolence Disorder

  • Chronic (3 months +) excessive daytime sleepiness despite prolonged 9+ hour night sleep.

  • Prolonged non-restorative sleep inertia upon awakening ("sleep drunkenness").

  • Treatment: Scheduled regular sleep patterns and wakefulness stimulants.

    • Pharmacotherapy: long- acting amphetamine-based stimulants such as methylphenidate and nonamphetamine-based stimulants such as modafinil (Provigil) 

AIRWAY & RESPIRATORY CONTROL - Breathing-Related Sleep Syndromes

• Physiological Rule:Patient cannot breathe and sleep at the same time; causes fragmented sleep architecture.

• OSAHS (Obstructive)

  • Upper airway collapse during sleep resulting in repeated oxyhemoglobin desaturations and sleep fragmentation 

  • Common symptoms: loud snoring, witnessed pauses in breathing (apnea), and excessive daytime sleepiness

  • Gold Standard: Polysomnography (diagnosis) & CPAP.

• Central Sleep Apnea

  • Transient cessation of respiratory drive without mechanical airway obstruction.

  • Associated with cardiac failure and CNS disease.

• Sleep Hypoventilation

  • Sustained elevated arterial pCO2 desaturations during sleep without frank apnea.

  • Correlates with morbid obesity and pulmonary pathology.

Other sleep disorders 

• Circadian rhythm sleep disorders: Occur when the body's internal sleep-wake cycle is misaligned with external demands

  • diagnosis uses clinical evaluation, sleep diaries, and actigraphy

  • treatment focuses on lifestyle changes to adjust the sleep schedule

    • Delayed sleep phase: Sleep and waking occur more than 2 hours later than desired; common in adolescents.

    • Advanced sleep phase: Sleep and waking occur several hours earlier than desired; more common with aging.

    • Irregular sleep-wake: Sleep is fragmented and sporadic, often associated with Alzheimer’s disease and disruptive environments.

    • Non-24-hour sleep-wake: The internal clock gradually shifts later each day, causing sleep during the daytime; common in blind individuals and treated with tasimelteon (Hetlioz), which acts on melatonin receptors.

    • Shift work: Night or evening work disrupts normal sleep patterns, causing excessive sleepiness at work and difficulty sleeping at home.

• NREM sleep arousal disorders: Include sleepwalking and sleep terrors during deep NREM sleep.

  • Sleepwalking: Walking or performing activities while unconscious; common in children and managed with safety precautions, good sleep hygiene, and sometimes benzodiazepines.

  • Sleep terrors: Sudden screaming, intense fear, and autonomic arousal with no memory afterward; managed with stress reduction, regular sleep habits, and rarely medication.

• Nightmare disorder: Repeated, frightening, well-remembered dreams occurring during REM sleep, usually late at night

  • managed with sleep hygiene, lifestyle changes, stress reduction, and sometimes hypnotic therapy

• REM sleep behavior disorder: Patients physically act out their dreams, risking injury; more common in older men and associated with Parkinson’s disease. 

  • Diagnosed by polysomnography with video; treatment focuses on safety and sometimes benzodiazepines.

• Restless Legs Syndrome (RLS): Uncomfortable leg sensations and an urge to move that worsen during rest/evening and improve with movement, disrupting sleep.

  • Associated with dopamine dysfunction, low iron, pregnancy, and certain medications. 

    • Triggers: SSRIs, SNRIs, antihistamines, and dopamine-blocking medications can worsen RLS; periodic limb movements may occur during sleep.

    • Treatment: Dopamine agonists (ropinirole, pramipexole, rotigotine), gabapentin enacarbil, iron supplements for deficiency, or off-label levodopa; long-term dopamine agonists may cause symptom worsening (augmentation). 

    • Relaxis (pad) provides leg vibration but should be avoided with recent DVT.

• Substance-Induced Sleep Disorder: Substances or medications disrupt sleep quality and duration.

  • Alcohol: Reduces deep and REM sleep, causing nighttime awakenings.

  • Nicotine: Stimulates the CNS and causes nighttime awakenings from withdrawal; remove nicotine patches at bedtime.

  • Caffeine: Blocks adenosine, increasing alertness, delaying sleep, and reducing deep sleep.

AROUSAL PHENOMENA & ASSESSMENT - Parasomnias & Diagnostic Modalities

• Assess sleep complaints over the entire 24-hour period; have patients complete a 2-week sleep diary to identify sleep patterns and behaviors affecting sleep and guide care.

• Patient Safety: Secure environment, gate stairwells, and clear bedroom floor obstacles for sleepwalkers.

  • Pittsburgh Sleep Quality Index (PSQI): Measures subjective sleep quality; scores ≥5 indicate poor sleep quality.

  • Epworth Sleepiness Scale (ESS): Measures daytime sleepiness; scores 15 indicate excessive sleepiness.

• Parasomnia Spectrum

  • Somnambulism:Sleepwalking during slow-wave Stage N3 sleep.

  • Night Terrors:Autonomic arousal and panic without dream recall.

  • REM Behavior Disorder:Loss of motor atonia; acting out violent dreams.

• Diagnostic Tools

  • Polysomnography (PSG):Gold standard overnight EEG, EMG, EOG study.

    • Monitors sleep over one or two nights in a lab using electrodes and sensors placed on the head, chest, and legs

  • Multiple Sleep Latency Test:Quantifies daytime sleep latency during naps.

    • used to diagnose suspected narcolepsy

  • Actigraphy:Wearable tracking device logging 2-week circadian activity (circadian rhythm disorders and insomnia) 

EVIDENCE-BASED THERAPY - CBT-I & Sleep Hygiene Protocols

• Shift-Work Nurse Health: Maintain dark quiet bedroom, limit overtime to 8-hour shifts, ensure 7-8 hours rest.

• Stimulus Control

  • Use the bed strictly for sleep and sex.

  • Leave bedroom if awake after 20 minutes.

  • Maintain a consistent sleep-wake schedule, especially waking up at the same time daily.

  • Avoid naps; if necessary, limit them to 20–30 minutes and set a time

• Sleep Restriction

  • Limit time in bed to actual total sleep time.

  • Increases homeostatic sleep efficiency.

• Eliminate Saboteurs

  • Prohibit late daytime napping.

  • Stop caffeine and alcohol >6 hours before bed.

• Pharmacotherapy: Long-term sleeping pills are discouraged; medications such as antidepressants, anticonvulsants, and antihistamines may be used off-label. Melatonin has limited evidence for treating insomnia.

• Somatic interventions: The Cerêve Sleep System cools the forehead to reduce brain activity and help initiate sleep.

• Psychological therapies (CBT-I): Uses education, behavioral strategies, and cognitive techniques to improve sleep habits, correct misconceptions, and focus on sleep quality and daytime functioning rather than hours slept.

PHYSIOLOGICAL FOUNDATION- Masters & Johnson Sexual Response Cycle

• Clinical Definition: Sexual dysfunction entails an involuntary disturbance in any cycle phase persisting ≥6 months with distress.

• PHASE 1: Desire

  • Psychological appetite and sexual fantasies initiating interest.  

  • Three components:

    • Drive: biologically motivated interest based in the cerebral cortex and the limbic and endocrine systems that prompts a focus on the sexually appealing aspects of another, physiological response, and plotting for connection.

    • Motive: psychological; based on choices, aspirations, and motives for interpersonal connection. This is the area that clinicians often target for intervention

    • Values: the familial, religious, and cultural beliefs and guidelines for responses and behaviors

  • Testosterone…essential to sexual desire in both men and women. Estrogen does not seem to have a direct effect on sexual desire in women… but is secondary for vaginal elasticity and lubrication.

• PHASE 2:Excitement

  • Period of time during which sexual tension continues to increase from the preceding level of sexual desire.

  • Vascular congestion, penile erection, and vaginal lubrication.

• PHASE 3:Orgasm

  • Rhythmic neuromuscular discharge and peak sexual tension release.

  • Sexual tension (also described as sexual arousal) is produced by a combination of mental activity—including thoughts, fantasies, and dreams—and erotic stimulation of erogenous areas, which may be more or less specific for each individual.

• PHASE 4:Resolution

  • Muscular relaxation, refractory period in males, resting return to baseline.

CLINICAL CATEGORIES- Major Diagnostic Classes of Sexual Dysfunction pt 1

• Etiological Screen: Always rule out antihypertensives, SSRIs, diabetes, and vascular disease.

Desire / Arousal

Male Hypoactive Desire: deficiency or absence of sexual fantasies or desire for sexual activity (present for 6 months).

• Reasons: physio or psycho; *Hormonal imbalance: testosterone deficiency and/or hyperprolactinemia. Depression is often implicated in a lack of desire for sexual intimacy in men. 

Female Sexual Interest/arousal Disorder: characterized by emotional distress caused by absent or reduced interest in sexual fantasies, sexual activity, pleasure, and arousal… present for 6 months.

• Reasons: abusive mate; neurobiological, hormonal, and psychosocial factors. 

• Comorbid: pain, depression, anxiety, thyroid, urinary incontinence

• Dopamine, progesterone, estrogen, and testosterone play an excitatory role

• Serotonin, prolactin, and opioids inhibit sexual desire.

• Deficient sexual fantasies.

Excitement

Erectile Disorder (ED):failure to obtain and maintain an erection sufficient for sexual activity.

• Inability to maintain rigidity on 75% of occasions for 6+ months.

• Vascular or psychogenic.

• Aging. Diseases that affect the vascular, neurological, and/or endocrine systems are implicated in this disorder. Ex. dyslipidemia, cardiovascular disease, hypogonadism, multiple sclerosis, and diabetes mellitus.

Orgasmic

Female Orgasmic Disorder aka inhibited female orgasm or anorgasmia: the recurrent or persistent inhibition of female orgasm. It is manifested by the recurrent delay in or absence of orgasm after a normal sexual excitement phase achieved by masturbation or coitus (for 6months)

• May be lifelong or acquired

• Medical conditions such as: multiple sclerosis, pelvic nerve damage, and spinal cord injuries can

• Psychiatric conditions, such as: major depressive disorder

• Some medications, such as: selective serotonin reuptake inhibitors (SSRIs), are known to delay

• Vulvovaginal atrophy and dryness associated with menopause can result in pain, thus preventing sexual pleasure

Premature Ejaculation (<1 min): persistently or recurrently achieves orgasm and ejaculation before he wishes to… 6 months.

• Physical factors may be involved… tactilely sensitivity differences. Psychological factors include fear about performance and stressful relationships where the man feels hurried. Considerations as to age, newness of the relationship, and how often the man has intercourse should be assessed 

• Also associated with: prostatitis, thyroid disease, or drug withdrawal, as from opioids.

CLINICAL CATEGORIES- Major Diagnostic Classes of Sexual Dysfunction pt 2

Delayed Ejaculation: achieves ejaculation during partnered sexual activity only with great difficulty… 6months.

• Lifelong delayed ejaculation: has never been able to ejaculate during sexual activity. Uncommon condition may result from a rigid background in which sex is believed to be a sin. 

  • Physically, it is associated with age-related loss of fastconducting peripheral sensory nerves and decreased sex steroid secretion. 

• Acquired delayed ejaculation: develops after previously normal functioning. Fairly common. Interpersonal problems may be the cause. Physical conditions, substance use, and prescribed medication may also cause this problem and should be assessed. 

• Comorbid: Major depressive disorder, diabetes, and late-onset hypogonadism are comorbidites for delayed ejaculation. Age-related disease treatments (e.g. surgical, medical, radiation) can also impact ejaculatory function 

Pelvic Pain

Genito-Pelvic Pain Disorder aka dyspareunia: pelvic and/or vaginal pain during or after intercourse. 

• Vaginismus: involuntary constriction of the muscles of the vagina. 

  • Marked penetration pain.

  • Anticipatory pelvic guarding→ relationship stress

  • Causes: physical problems such as urinary/vaginal infection, endometriosis, irritable bowel syndrome, and constipation. 

Other Sexual Dysfunction and Problems

Sexual dysfunction due to a general medical condition includes: sexual desire disorders, orgasm disorders, and sexual pain disorders. 

• The cause of each is related to a medical condition, such as cardiovascular, neurological, or endocrine disease. 

Substance-induced sexual dysfunction: evidence of substance intoxication or withdrawal is apparent from the history, physical examination, or laboratory findings. 

• Ex: alcohol, amphetamines or related substances, cocaine, opioids, sedatives, hypnotics, antianxiety agents, and other known and unknown substances. 

• Abused recreational substances can have a variety of effects on sexual functioning. 

• In small doses, many substances enhance sexual performance. With continued use, sexual difficulties become the norm.

Sexual dysfunction not elsewhere classified: a category that covers sexual dysfunctions that cannot be classified under one of the other categories. 

• Typically, this is because their presentation is not quite strong enough to meet the criteria for a disorder or because there is not enough information to make a diagnosis 

• syndrome, and constipation. 

Sexual Dysfunction risk factors

• Biological: aging

• Cognitive: According to Helen Singer Kaplan, sexual dysfunction is because:

  • Misinformation or ignorance regarding sexual and social interaction 

  • Unconscious guilt and anxiety regarding sex 

  • Anxiety related to performance, especially with erectile and orgasmic dysfunction 

  • Poor communication between partners about feelings and what they desire sexually 

  • Others include: Unacknowledged or unidentified sexual orientation

SEXUAL ORIENTATION CLARIFICATION- Asexuality vs. Hypoactive Sexual Desire

• Case Synthesis (Allyson):Reassurance that her absence of desire is a normal asexual orientation variant.

• HEALTHY ORIENTATION VARIANT

  • Asexuality

    • Inherent lack of sexual attraction to any gender.

    • Individuals feel zero inner personal distress about low sexual attraction.

    • Valid human sexual orientation; NOT a pathology.

• CLINICAL DISORDER

  • Hypoactive Sexual Desire

    • Distressing absence or loss of previously experienced desire.

    • Causes profound emotional distress and relationship turmoil.

    • Meets DSM criteria for therapeutic intervention.

THERAPEUTIC COMMUNICATION- Sexual Health Assessment & Self-Reflection

• Treatment Interventions: 

• Premenopausal women with acquired generalized hypoactive sexual desire disorder. 

  • Flibanserin (Addyi): boosts dopamine and norepinephrine (both responsible for sexual excitement) while decreasing levels of serotonin … dosed at bedtime because it poses risks of hypotension, syncope, and sedation.

  • Bremelanotide (Vyleesi): which is a subcutaneous injection given at least 45 minutes prior to sexual activity for up to eight times in a month. 

  • Testosterone pills, patches, and gels are also prescribed off label for treating sexual dysfunction in women. 

• Medication adjustment: Waiting to see whether sexual side effects decrease over time... Reducing the dose of the antidepressant... Planning for sexual activity before taking the antidepressant… For men, add a phosphodiesterase inhibitor such as sildenafil citrate (Viagra)... Switching to an antidepressant with a more favorable side effect profile, such as mirtazapine (Remeron), bupropion (Wellbutrin), or vilazodone (Viibryd). 

• Sensate focus: A therapeutic treatment in which patients progress from general touching and cuddling without intercourse to more intimate forms of expression

• Behavioral therapy: Useful for men with premature ejaculation when psychogenic or relationship factors are present—often best combined with medication in an integrated treatment program

• Systematic desensitization: Relaxation exercises combined with sexual anxiety–producing stimuli.

• Masturbation training: Especially helpful for women who have never had an orgasm. This approach helps women learn about their bodies and their sexual responsiveness. 

• Patient Behavioral Cues

  • Blushing, hesitations, or overt inappropriate jokes.

  • Guarded questions regarding medication sexual side effects.

• Nurse Self-Assessment

  • Identify personal discomfort, moral judgments, or embarrassment.

  • Remember: sexuality assessment is integral holistic care.

• Environmental Privacy

  • Conduct interviews in private, distraction-free rooms.

  • Maintain neutral tone, open posture, and minimal notetaking.

IDENTITY DEVELOPMENT - Gender Dysphoria Across the Lifespan

• Suicide Prevention:Severe comorbidities include depression and bullying; affirmation drastically reduces self-harm.

• Core Clinical Definition

  • Significant, persistent emotional unease resulting from incongruence between experienced gender and assigned natal sex.

  • Gender identity develops around age 3; 

  • Symptoms in children include expressions of desire to be the opposite sex. Some children insist that they are the opposite sex and ask their families to call them by another name

  • Post-puberty:Dressing up and passing for the opposite sex is common. Appearance of secondary sexual characteristics and (along with adults) may seek hormones or surgery to alter their masculinity or femininity

  • Comorbid: anxiety, impulse-control problems, be disruptive, and have depressive disorders. Autism spectrum disorder has also been associated with gender dysphoria. In adolescents and adults, anxiety disorders are most common, followed by mood disorders. 

  • Substance use and self-destructive behavior are also common parallels found in people suffering from gender dysphoria

• Risk Factors: Hormone levels, some genetic, cognitive (freud ahh explanation)

• Pediatric Support

  • Family-directed counseling, social support, and psychological well-being optimization.

• Adolescent / Adult Care

  • Pubertal suppression (give GnRH. Controversial), gender-affirming hormone therapy, and surgical alignment. must address the psychological to make sure they are sure

• Surgery:removal of the penis (penectomy) and testes (orchiectomy) and the addition of a vagina (vaginoplasty). 

• In females, surgical procedures may include the removal of the breasts (mastectomy), optional removal of the uterus (hysterectomy) and ovaries (oophorectomy), and the construction of a penis (phalloplasty) in females

• Pharm: hormone therapy:

• A female who would like to become a male takes testosterone. 

  • In the first 6 months, this results in skin oiliness and acne, fat redistribution, cessation of menses, clitoral enlargement, vaginal atrophy, and amenorrhea… Within a year→ experience the growth of facial and body hair, loss of scalp hair, increasing muscle mass, and deepening of the voice.

• A male takes estrogen, within the first 2 months his libido declines and spontaneous erections decrease. Within 3 to 6 months of taking transfeminine hormone, he will experience softening of the skin, decreased testicular volume, less muscle, more fat on the hips, and breast growth.

ATYPICAL SEXUAL BEHAVIORS - Paraphilic Disorders: Criteria & Spectrum

• Diagnostic Threshold: Paraphilia becomes a Disorder only when causing distress, impairment, or acting on nonconsenting victims.

• Define: acts or sexual stimuli that are outside of what society considers normal but are required by some individuals to experience desire, arousal, and orgasm

• Risk: head trauma, reinforcement during puberty, cognitive distortions

Exhibitionistic: illegal and intentional display of one’s genitals in a public place

• Genital exposure to nonconsenting strangers.

• Although these behaviors are illegal, they are apparently engaged in more for shock value than as a precursor to sexual assault or rape. Actual contact is rarely sought.

• Comorbid: criminal convictions of individuals who have exposed themselves, depression, bipolar, anxiety, and substance use disorders. Hypersexuality, other paraphilic disorders, attention-­ deficit/hyperactivity disorder, and antisocial personality disorder.

Voyeuristic

• Secretly observing unsuspecting naked individuals.

• Voyeurism may be driven by anger and a need to retaliate. Typically, people who engage in voyeurism also engage in other compulsive sexual behavior and are frequently addicted to pornography and going to strip clubs.

• Dissonance, the shame and anxiety are temporarily relieved by engaging in the very activity that brings it about

Frotteuristic

• Rubbing against nonconsenting persons in crowds.

• Comorbid conditions include other paraphilic disorders, especially exhibitionistic disorder. Conduct disorder, antisocial personality disorder, depression, bipolar, anxiety, and substance use disorders

Fetishistic

• Sexual focus centered on inanimate bodily objects.

SAFETY & HARM PREVENTION - Severe Paraphilias & Harm Potential

Mandatory Action: Nurses must immediately protect potential victims and follow state reporting statutes.

Pedophilic Disorder: Most common.

• Sexual attraction toward prepubescent children (≤13 years). Hebephilia (11-14 yr)

• For the definition of pedophilia to be met, the perpetrator must be at least 16 years of age and at least 5 years older than the victim.

• High recidivism; requires strict legal and medical boundaries.

• Comorbid: substance use disorders and depression as well as bipolar, anxiety, and antisocial personality disorder and other paraphilic disorders.

Sexual Sadism

• Arousal derived from physical/psychological suffering of victim.

• Significant danger of progressive lethal escalation.

Sexual Masochism

• Arousal from being humiliated, beaten, or bound.

• Hypoxyphilia carries lethal autoerotic asphyxiation risk.

Transvestic Disorder: sexual satisfaction is achieved by dressing in the clothing of the opposite gender. No sexual orientation issues

• Transvestism is frequently comorbid with other paraphilic disorders. The most common are fetishism and masochism. 

• Autoerotic asphyxia by cutting off one’s air supply during orgasm is associated with transvestism in a high proportion of fatal cases.

Paraphilic Disorder Not Otherwise Specified

Telephone scatalogia disorder: Obscene phone calling to an unsuspecting person or sending obscene messages or video images by e-­ mail.

•  Necrophilic disorder: Obsession with having a sexual encounter with a cadaver. 

•  Zoophilic disorder: Incorporation of animals into sexual activity.

•  Coprophilic disorder: Fixation on feces in sexual encounters.

•  Klismaphilic disorder: Sexual activity that incorporates enemas.

•  Urophilic disorder: Sexual activity that involves urinating on one’s partner or being urinated on.

•  Hypoxyphilia: Desire to achieve an altered state of consciousness secondary to hypoxia while experiencing orgasm; a drug such as nitrous oxide may be used to produce hypoxia.

THERAPEUTIC INTERVENTIONS- Paraphilia Interventions & Pharmacology

• Ethical Care:Maintain professional objectivity; unexamined nurse disgust impedes therapeutic safety.

• Suicide risk (from the guilt/shame), forensics, COPING strategy, finding triggers, improve self esteem, improve support systems,

• Biological Interventions

  • Antiandrogens (GnRH Agonists): Progestin; Cyproterone=Suppress testosterone, dramatically lowering compulsive sexual fantasies.

  • SSRIs:Reduce obsessive sexual imagery and impulsivity.

  • clomipramine (Anafranil) and fluvoxamine (Luvox), have been used in the treatment of sexual obsessions, addictions, and paraphilic disorders.

• Psychotherapy & Relapse

  • Cognitive Behavioral Therapy:Cognitive restructuring of victim empathy and cognitive distortions.

  • Relapse Prevention:Identify high-risk cues and manage triggers.

  • Positive reinforcement for appropriate object choices

  • Aversion techniques, in which mild electrical shocks may be applied for inappropriate choices.

DISRUPTIVE PATTERNS- Oppositional Defiant Disorder (ODD)

• Oppositional defiant disorder affects both emotions (e.g., anger and irritation) and behaviors (e.g., argumentativeness and defiance).

•  This disorder impairs the child’s life and makes school functioning, friendships, and family life extremely difficult.

• Epidemiology & Comorbidity:Diagnosed around age 8; higher in males; most commonly comorbid with ADHD.

• Angry / Irritable Mood

  • Frequent temper tantrums, touchy, easily annoyed, highly resentful.

• Defiant Behavior

  • Argues with authority, refuses to comply with rules, blames others for mistakes.

• Vindictiveness

  • Spiteful or vindictive actions occurring at least twice within a 6-month period.

• Environmental Factors

  • Adverse childhood experiences (ACEs) are associated with oppositional defiant disorder and other impulse control disorders that continue into adulthood 

VIOLATIONS OF RIGHTS & NORMS - Conduct Disorder (CD)

• Conduct disorder is a persistent pattern of behavior in which the rights of others are violated and societal norms or rules are disregarded. 

• The behavior is usually abnormally aggressive and can frequently lead to the destruction of property or physical injury.

• Individuals with this disorder initiate physical fights and engage in bullying. They may steal or use a weapon to intimidate or hurt others.

• Callous-Unemotional Traits: Profound lack of guilt, remorse, or empathy signifies severe prognosis.

• Core Hallmarks

  • Aggression to People & Animals:Bullying, weapon use, physical cruelty, forced sexual acts.

  • Destruction of Property:Deliberate arson and vandalism.

  • Deceitfulness or Theft:Breaking and entering, cons, and severe rule breaking.

• Childhood-Onset (<10 yrs)

  • High risk for developing adult Antisocial Personality Disorder.

• Adolescent-Onset

  • Less aggressive, better peer attachments, improved therapeutic prognosis.

• Comorbidities

  • ADHD and oppositional defiant disorder are both common among people with conduct disorder.

  • The combination of these makes the worse outcomes TT

• Environmental Factors

  •  conduct disorder is highly associated with ACEs.

IMPULSIVE AGGRESSION - Intermittent Explosive Disorder (IED)

• Intermittent explosive disorder is a pattern of behavioral outbursts characterized by an inability to control one’s aggressive impulses. 

• The aggression can be verbal or physical and is targeted toward other people, animals, property, or even oneself.

• Anything can trigger the aggressive reaction to the situation. 

• Key Distinction from CD: IED outbursts are sudden, affective, and impulsive, not premeditated predatory cruelty.

• Recurrent Outbursts

  • Inability to resist aggressive impulses triggered by minor provocation.

  • Grossly disproportionate reaction.

• Physical Consequences

  • Somatic tension and autonomic surge followed by guilt and remorse.

  • Correlates with chronic hypertension.

• Occupational / Legal

  • Severe employment termination, domestic violence charges, and jail.

  • Usually appears ≥6 years of age. 

• Comorbidities 

  • The most commonly associated comorbid conditions associated with intermittent explosive disorder are depressive disorders, anxiety disorders, and substance use disorders. borderline personality disorder, ADHD, and a history of the other disruptive disorders

• Environmental Factors

  • Intermittent explosive disorder is associated with trauma, particularly conflict and violence in the family of origin

  • Impulsivity and aggression are distinctive characteristics of intermittent explosive disorder and are also risk factors for suicide (self- aggression).

ISOLATED IMPULSE PATHOLOGIES - Pyromania & Kleptomania

• Differential:Theft and fire setting are not done for monetary gain, revenge, or political motives.

• Pyromania

  • Repeated, deliberate, and purposeful fire setting.

  • Tension or affective arousal prior to setting the fire.

  • Pleasure, gratification, or relief when witnessing consequences.

  • Pyromania occurs more often in males, particularly those who have poor social skills and learning difficulties

  • Individuals with pyromania often have a history of alcohol or substance use.

  •  Juvenile fire setting is usually associated with conduct disorder or ADHD.

• Kleptomania

  • Recurrent failure to resist stealing unneeded objects.

    • Basically they just steal for fun, they don't even need the item. 

  • Surge of tension immediately before theft.

  • Relief or gratification at time of theft; stolen items often discarded.

  • Also associated with mood disorders, such as major depressive disorder, anxiety, disorders, eating disorders (particularly bulimia nervosa), and personality disorders.

• EXPLORE SUICIDE RISK FOR BOTH

• expressed emotion refers to the qualitative amount of emotion displayed, usually in the context of family interactions.

MULTIFACTORIAL ETIOLOGY - Neurobiology of Impulse Control Disorders

• Clinical Pearl: Blunted stress reactivity explains why standard punishment fails to deter antisocial behavior.

• Genetic & Endocrine

  • Strong familial inheritance of impulse disorders.

  • Blunted cortisol reactivity to acute stress.

• Prefrontal Pathology

  • Reduced gray matter in the prefrontal cortex.

  • Amygdala hyperactivity; impaired serotonergic modulation.

• Environmental Factors

  • Harsh, inconsistent, punitive parenting.

  • Severe childhood neglect and community violence.

ETHICAL NURSING MANDATE - Overcoming Negative Countertransference of Impulse Control Disorders

• Self-Care: Regularly debrief with clinical colleagues after managing violent or manipulative crises.

• Common Biased Beliefs

  • Believing the patient is choosing not to get better.

  • Viewing aggressive actions strictly as moral deficits rather than neurochemical disorders.

  • Believing safety concerns are exaggerated by staff.

• Professional Responsibility

  • Provide unconditional equal care and avoid retaliatory punishment.

  • Understand patient's background of relentless negative environmental reinforcement.

  • Maintain consistent therapeutic boundaries.

MULTIMODAL THERAPEUTICS - Pharmacology & Evidence Psychotherapies of Impulse Control Disorders

• Rule:Medication alone never replaces comprehensive family behavior management therapy.

• Pharmacotherapy Regimens

  • Antipsychotics: Risperidone & Aripiprazole reduce aggression.

  • Mood Stabilizers: Divalproex sodium (Depakote) for explosive rage.

  • SSRIs & Beta-Blockers:Mitigate impulsive anger.

  • Avoid Benzodiazepines: Paradoxical disinhibition.

• Psychological Modalities

  • Parent Management Training (PMT):Reinforce prosocial behavior.

  • Multisystemic Therapy (MST):Intensive community and family systems work.

  • Dialectical Behavioral Therapy (DBT):Distress tolerance & mindfulness.